Two WWE Names Set to Return to GCW’s Bloodsport XIV

Josh Barnett’s Bloodsport XIV just got a serious injection of grit with the return of two names straight from WWE and NXT.

Pete Dunne and Charlie Dempsey have been officially added to the card, joining a growing list of violent technicians ready to throw down on August 2 in Rutherford, New Jersey.

Barnett made the announcement himself, confirming that Pete Dunne will return to Bloodsport after his debut win over Timothy Thatcher back in April. Since then, Dunne’s TV presence has dwindled, mostly popping up on WWE Main Event. He’s only wrestled three times since that first Bloodsport appearance, with his last match taking place in May.

Joining him is Charlie Dempsey, who’s becoming a familiar face at Bloodsport. This will be his fifth time entering the pit, and he holds a 3-1 record in the format. Dempsey made his debut in April 2024 by defeating Matt Makowski, stumbled in July with a loss to Royce Isaacs, then bounced back strong with wins over Tracy Williams and Shinya Aoki. Dempsey’s no stranger to this style—and he’s dangerous in it.

Also returning to the shoot-style event is GCW regular Slade. Though he hasn’t competed in Bloodsport since a March 2022 loss to Alex Coughlin, Slade’s reputation for chaos still looms large. Bloodsport XIV will stream live on Triller+, with the card already stacking up. Here’s the current lineup:

• Natalya vs. Masha Slamovich
• Janai Kai vs. Jordan Blade
• Pete Dunne in action
• Charlie Dempsey in action
• Timothy Thatcher in action
• Slade in action
• Jonathan Gresham in action
• Nick Comoroto in action
• Simon Gotch in action
• Matt Mako in action
• Dominic Garrini in action

Josh Barnett’s Bloodsport has always been about no ropes, no nonsense, and pure violence—and this lineup is only getting nastier. With Dunne and Dempsey stepping back into the pit, expect stiff shots and no mercy.

Which match are you most looking forward to at Bloodsport XIV? Will Pete Dunne and Charlie Dempsey steal the show? Sound off in the comments below.